Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Charles River Laboratories cooperation agreement with Elliott
We are advising Charles River on the agreement
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Denali Therapeutics $207 million stock offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $207…
Zai Lab $300 million follow-on offering of ADSs
Davis Polk advised Zai Lab Limited in connection with its follow-on offering of approximately $300 million of American…
Applied Therapeutics $143.4 million stock offering
Davis Polk advised the underwriters in connection with the SEC-registered offering of 3,152,712 shares of common stock of…
I-Mab $103.7 million IPO and Nasdaq listing
Davis Polk advised the underwriters on the SEC-registered initial public offering by I-Mab of 7,407,400 American depositary…
Davis Polk Advises Charles River on Its Acquisition of HemaCare
Davis Polk is advising Charles River Laboratories International, Inc. on its approximately $380 million acquisition of…
Davis Polk Advises Notre Dame Intermédica on Its R$5.0 Billion Equity Offering
Davis Polk advised Notre Dame Intermédica Participações S.A. in connection with the equity offering by Notre Dame…
Forty Seven, Inc. $195.6 Million Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $195…
Constellation Pharmaceuticals Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the …
Davis Polk Advises Venus Medtech (Hangzhou) Inc. on Its HK$2.59 Billion (US$331.17 Million) Initial Public Offering
Davis Polk advised Venus Medtech (Hangzhou) Inc. in connection with its initial public offering and listing on the Hong Kong…
IVERIC bio, Inc. Common Stock and Pre-Funded Warrants Offering
Davis Polk advised the sole book-running manager and representative of the several underwriters in connection with a $45…